missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18331602

BAP1 Antibody (BAP1/2432) - Azide and BSA Free, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Bio-Techne NBP3-08493

Product Code. 18331602

  • 606.00 EUR / 100µg

Please to purchase this item. Need a web account? Register with us today!

Explore more special offers
This item is not returnable. View return policy

Description

Description

BAP1 Monoclonal specifically detects BAP1 in Human samples. It is validated for ELISA, Protein Array.
Specifications

Specifications

BAP1
Monoclonal
1 mg/mL
ELISA, Protein Array
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase), BRCA1-associated protein 1, Cerebral protein 6, cerebral protein-13, cerebral protein-6, DKFZp686N04275, EC 3.4.19.12, FLJ35406, FLJ37180, hucep-6, KIAA0272HUCEP-13, ubiquitin carboxyl-terminal hydrolase BAP1, ubiquitin carboxy-terminal hydrolase, UCHL2
Recombinant human BAP1 protein fragment (around aa 191-326) (exact sequence is proprietary)
100 μg
Apoptosis, Breast Cancer, Cancer, Cell Cycle and Replication, Chromatin Research, DNA Repair, Tumor Suppressors
8314
Store at -20 to -80C. Avoid freeze-thaw cycles.
IgG2c κ
ELISA, Peptide Array
BAP1/2432
Unconjugated
10mM PBS
Mouse
Protein A or G purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Special Offers

Special Offers

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.